These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 185445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex.
    Palmer GC.
    Neuropharmacology; 1976 Jan; 15(1):1-7. PubMed ID: 176608
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of motility in immature bovine spermatozoa by cyclic AMP phosphodiesterase inhibitors and seminal plasma.
    Hoskins DD, Hall ML, Munsterman D.
    Biol Reprod; 1975 Sep; 13(2):168-76. PubMed ID: 177102
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of adenosine-3',5'-cyclic monophosphate phosphodiesterase by potential antiallergic compounds.
    Tateson JE, Trist DG.
    Life Sci; 1976 Jan 15; 18(2):153-61. PubMed ID: 56695
    [No Abstract] [Full Text] [Related]

  • 12. Concanavalin A ibhibition of liver plasma membrane-bound cyclic AMP-phosphodiesterase.
    Luly P, Scapin S, Ferretti E, Tomasi V.
    FEBS Lett; 1976 Apr 15; 64(1):209-13. PubMed ID: 178544
    [No Abstract] [Full Text] [Related]

  • 13. Influence of papaverine derivatives on phosphodiesterase activity, cyclic 3',5'-AMP levels and relaxing effect on rabbit ileum.
    Berndt SF, Schulz HU, Stock K.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep 15; 294(3):271-5. PubMed ID: 187961
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G, Prigent AF.
    Ann Pharm Fr; 1984 Sep 15; 42(2):99-112. PubMed ID: 6091520
    [No Abstract] [Full Text] [Related]

  • 15. An endogenous inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase.
    Wallace RW, Lynch TJ, Tallant EA, Cheung WY.
    Arch Biochem Biophys; 1978 Apr 30; 187(2):328-34. PubMed ID: 208465
    [No Abstract] [Full Text] [Related]

  • 16. Effect of thyroid hormone on cyclic AMP phosphodiesterase in rat kidney.
    Hagino Y, Uematsu T, Tachibana M, Tsuru H.
    Jpn J Pharmacol; 1980 Aug 30; 30(4):521-8. PubMed ID: 6162987
    [Abstract] [Full Text] [Related]

  • 17. The cyclic AMP system and drug development.
    Smith CG.
    Adv Enzyme Regul; 1974 Aug 30; 12():187-203. PubMed ID: 4156822
    [No Abstract] [Full Text] [Related]

  • 18. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A, Schultz J.
    Experientia; 1975 Aug 15; 31(8):883-4. PubMed ID: 169139
    [No Abstract] [Full Text] [Related]

  • 19. RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations.
    Hunt NH, Evans T.
    Biochim Biophys Acta; 1980 Jun 13; 613(2):499-506. PubMed ID: 6256001
    [Abstract] [Full Text] [Related]

  • 20. Antispasmodic action of 1-diethylaminoethyl-3-(p-methoxybenzyl)-2-quinoxalone (P 201-1) and its inhibitory effect on cyclic 3',5'-nucleotide phosphodiesterase (PDE) activity.
    Hayashi S, Ozawa H.
    Chem Pharm Bull (Tokyo); 1975 Apr 13; 23(4):810-6. PubMed ID: 171085
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.